The company is a high-tech enterprise founded in 2000, characterized by chemically synthesizing polypeptide drugs. It specializes in the production, sales and development of chemically synthesized polypeptide drugs. The company has formed a complete mature technical process system in the synthesis, purification, analysis, quality assurance, activity determination, and formulation process of chemically synthesized polypeptide drugs. The company was listed on the small to medium edition of the Shenzhen Stock Exchange on August 8, 2012. The company's main business covers R&D, production and sales of pharmaceutical injections, solid preparations, and APIs. The company's main products are injectable thymus, injectable somatostatin, injectable bivalirudine, and etibatide injections. Corporate honors: National Torch Program Project Certificate; High-tech Enterprise in Hainan Province; 2002 Honest Tax Paying Enterprise; Famous Trademark of Hainan Province, etc.
No Data